Patient preferences for allogeneic haematopoietic stem cell transplantation: how much benefit is worthwhile from the patient’s perspective?

Oncological studies have shown that patients consider small benefits sufficient to make adjuvant chemotherapy worthwhile. We sought to determine the minimal survival benefits that patients considered enough to legitimate allogeneic haematopoietic stem cell transplantation (HCT) and the factors assoc...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Support Care Cancer
Главные авторы: Leuthold, Nicolas, Cattaneo, Marco, Halter, Jörg, Hügli, Claudia, Kirsch, Monika, Petropoulou, Anna, Erlanger, Tobias E., Gerull, Sabine, Passweg, Jakob, O’Meara Stern, Alix
Формат: Artigo
Язык:Inglês
Опубликовано: Springer Berlin Heidelberg 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8062338/
https://ncbi.nlm.nih.gov/pubmed/33067766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-020-05816-z
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы